SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. preventive services task force recommendation statement DRAFT. 2011. Available at: http://www.uspreventiveservicestaskforce.org/uspstf12/prostate/draftcecprostate.htm. Accessed 19 March 2012
  • 2
    American Urological Association. Prostate-specific antigen best practice statement: 2009 update. 2009
  • 3
    NCCN Clinical Practice Guidelines in Oncology. Prostate cancer early detection version 1. 2011. Available at: http://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf. Accessed 15 December 2011
  • 4
    Heidenreich A, Bolla M, Joniau S et al. European Association of Urology. Guidelines on prostate cancer. 2011
  • 5
    Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 90916
  • 6
    Glenski WJ, Klee GG, Bergstralh EJ, Oesterling JE. Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrations. Prostate 1992; 21: 99110
  • 7
    Preston DM, Levin LI, Jacobson DJ et al. Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology 2000; 56: 8126
  • 8
    Hartzell JD, Kao T-C, Holland JC, Holt SR, Moul JW. Age-specific reference ranges for prostate specific antigen in young men: retrospective study from the National Defense University. The Prostate Journal 2001; 3: 3641
  • 9
    Naselli A, Fontana V, Introini C, Andreatta R, Puppo P. Effect of age, family history of prostate cancer, prostate enlargement and seasonality on PSA levels in a contemporary cohort of healthy Italian subjects. Int J Biol Markers 2011; 26: 1027
  • 10
    Kuller LH, Thomas A, Grandits G, Neaton JD. Elevated prostate-specific antigen levels up to 25 years prior to death from prostate cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 3737
  • 11
    Whittemore AS, Cirillo PM, Feldman D, Cohn BA. Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans. J Urol 2005; 174: 8726; discussion 6
  • 12
    Lilja H, Cronin AM, Dahlin A et al. Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. Cancer 2011; 117: 12109
  • 13
    Silverberg MJ, Brundage JF, Rubertone MV. Timing and completeness of routine testing for antibodies to human immunodeficiency virus type 1 among active duty members of the U.S. Armed Forces. Mil Med 2003; 168: 1604
  • 14
    Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med 1996; 335: 30410
  • 15
    Oesterling JE, Jacobsen SJ, Chute CG et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270: 8604
  • 16
    Lein M, Koenig F, Jung K et al. The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy men. Br J Urol 1998; 82: 2316
  • 17
    Chautard D, Daver A, Mermod B, Tichet A, Bocquillon V, Soret J. Values for the free to total prostate-specific antigen ratio as a function of age: necessity of reference range validation. Eur Urol 1999; 36: 1816
  • 18
    Wolff JM, Borchers H, Rohde D, Jakse G. Age related changes of free and total prostate specific antigen in serum. Anticancer Res 1999; 19: 262932
  • 19
    Borgermann C, vom Dorp F, Swoboda A, Ketteniss O, Becker M, Rubben H. PSA quo vadis? It is reasonable to start with prostate-specific antigen testing at the age of 40! Cancer Epidemiol Biomarkers Prev 2011; 20: 11905
  • 20
    Wallace EM, Pye SD, Wild SR, Wu FC. Prostate-specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception. Int J Androl 1993; 16: 3540
  • 21
    Oremek GM, Seiffert UB. Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations. Clin Chem 1996; 42: 6915
  • 22
    Heidenreich A, Vorreuther R, Neubauer S, Westphal J, Engelmann UH, Moul JW. The influence of ejaculation on serum levels of prostate specific antigen. J Urol 1997; 157: 20911
  • 23
    Cooper CS, Perry PJ, Sparks AE, MacIndoe JH, Yates WR, Williams RD. Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men. J Urol 1998; 159: 4413
  • 24
    Roehrborn CG, Boyle P, Gould AL, Waldstreicher J. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 1999; 53: 5819
  • 25
    Bhasin S, Woodhouse L, Casaburi R et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 2001; 281: E117281
  • 26
    Linton HJ, Marks LS, Millar LS, Knott CL, Rittenhouse HG, Mikolajczyk SD. Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease. Clin Chem 2003; 49: 2539
  • 27
    Xu X, Valtonen-Andre C, Savblom C, Hallden C, Lilja H, Klein RJ. Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels. Cancer Epidemiol Biomarkers Prev 2010; 19: 203542
  • 28
    Korrovits P, Ausmees K, Mandar R, Punab M. Seminal interleukin-6 and serum prostate-specific antigen as possible predictive biomarkers in asymptomatic inflammatory prostatitis. Urology 2011; 78: 4426
  • 29
    Laffin RJ, Chan DW, Tanasijevic MJ et al. Hybritech total and free prostate-specific antigen assays developed for the Beckman Coulter access automated chemiluminescent immunoassay system: a multicenter evaluation of analytical performance. Clin Chem 2001; 47: 12932
  • 30
    Siegel R, Ward E, Brawley O, Jemal A, Cancer statistics. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 21236
  • 31
    Eastham JA, Sartor O, Richey W, Moparty B, Sullivan J. Racial variation in prostate specific antigen in a large cohort of men without prostate cancer. J la State Med Soc 2001; 153: 1849
  • 32
    Lin WY, Gu CJ, Kao CH, Changlai SP, Wang SJ. Serum prostate-specific antigen in healthy Chinese men: establishment of age-specific reference ranges. Neoplasma 1996; 43: 1035
  • 33
    Kao CH. Age-related free PSA, total PSA and free PSA/total PSA ratios: establishment of reference ranges in Chinese males. Anticancer Res 1997; 17: 13615
  • 34
    Lee SE, Kwak C, Park MS, Lee CH, Kang W, Oh SJ. Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population. Urology 2000; 56: 100710
  • 35
    Ku JH, Ahn JO, Lee CH et al. Distribution of serum prostate-specific antigen in healthy Korean men: influence of ethnicity. Urology 2002; 60: 4759
  • 36
    Ahn JO, Ku JH. Relationship between serum prostate-specific antigen levels and body mass index in healthy younger men. Urology 2006; 68: 5704
  • 37
    Choi YD, Kang DR, Nam CM et al. Age-specific prostate-specific antigen reference ranges in Korean men. Urology 2007; 70: 11136
  • 38
    Chang IH, Han JH, Ahn SH. Association of obesity with prostate specific antigen and prostate specific antigen velocity in healthy young men. J Urol 2008; 179: 88690; discussion 90–1
  • 39
    Park JH, Cho BL, Kwon HT, Lee CM, Han HJ. Effect of body mass index and waist circumference on prostate specific antigen and prostate volume in a generally healthy Korean population. J Urol 2009; 182: 10610; discussion 10–1
  • 40
    Yuan XD, Dong ZG, Zhang H et al. Distribution of serum prostate-specific antigen in Chinese healthy men: a population-based study. Chin Med J (Engl) 2011; 124: 118992
  • 41
    He D, Wang M, Chen X et al. Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population. Urology 2004; 63: 7226
  • 42
    American Cancer Society. Global Cancer Facts & Figures, 2nd edn. Atlanta, GA: American Cancer Society, 2011
  • 43
    Tchetgen MB, Song JT, Strawderman M, Jacobsen SJ, Oesterling JE. Ejaculation increases the serum prostate-specific antigen concentration. Urology 1996; 47: 5116
  • 44
    Herrmann M, Scharhag J, Sand-Hill M, Kindermann W, Herrmann W. Long-distance mountain biking does not disturb the measurement of total, free or complexed prostate-specific antigen in healthy men. Clin Chem Lab Med 2004; 42: 3479
  • 45
    Luboldt HJ, Peck KD, Oberpenning F, Schmid HP, Semjonow A. Bicycle riding has no important impact on total and free prostate-specific antigen serum levels in older men. Urology 2003; 61: 117780
  • 46
    Safford HR 3rd, Crawford ED, Mackenzie SH, Capriola M. The effect of bicycle riding on serum prostate specific antigen levels. J Urol 1996; 156: 1035
  • 47
    Leventhal EK, Rozanski TA, Morey AF, Rholl V. The effects of exercise and activity on serum prostate specific antigen levels. J Urol 1993; 150: 8934
  • 48
    Banez LL, Hamilton RJ, Partin AW et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298: 227580
  • 49
    US Department of the Army. AR 600-9 The Army Weight Control program. 2006. Available at: http://www.army.mil/USAPA/epubs/pdf/r600_9.pdf. Accessed 15 December 2011
  • 50
    Swain RA, Montalto N, Ross D. The effect of long-distance cycling on the prostate-specific antigen level. Arch Fam Med 1997; 6: 5002
  • 51
    Kratz A, Lewandrowski KB, Siegel AJ et al. Effect of marathon running on total and free serum prostate-specific antigen concentrations. Arch Pathol Lab Med 2003; 127: 3458
  • 52
    Pannek J, Berges RR, Cubick G, Meindl R, Senge T. Prostate size and PSA serum levels in male patients with spinal cord injury. Urology 2003; 62: 8458
  • 53
    Baillargeon J, Pollock BH, Kristal AR et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005; 103: 10925
  • 54
    Malati T, Kumari GR. Racial and ethnic variation of PSA in global population: age specific reference intervals for serum prostate specific antigen in healthy South Indian males. Indian J Clin Biochem 2004; 19: 1327
  • 55
    Kirkali Z, Kirkali G, Esen A. Effect of ejaculation on prostate-specific antigen levels in normal men. Eur Urol 1995; 27: 2924
  • 56
    Kehinde EO, Mojiminiyi OA, Sheikh M et al. Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men. BJU Int 2005; 96: 30812
  • 57
    Saka T, Sofikerim M, Demirtas A, Kulaksizoglu S, Caniklioglu M, Karacagil M. Rigorous bicycling does not increase serum levels of total and free prostate-specific antigen (PSA), the free/total PSA ratio, gonadotropin levels, or uroflowmetric variables. Urology 2009; 74: 132530
  • 58
    Saw S, Aw TC. Age-related reference intervals for free and total prostate-specific antigen in a Singaporean population. Pathology 2000; 32: 2459